September 19-21, 2025
Grand Hyatt Denver
Denver, Colorado

sign up to request additional information

Conference Cochairs:

Ronald Bukanovich, Magee-Womens Research Institute, Pittsburgh, Pennsylvania
Jung-Min Lee, National Cancer Institute, Bethesda, Maryland
Elizabeth M. Swisher, University of Washington, Seattle, Washington
Oladapo Yeku, Massachusetts General Hospital, Boston, Massachusetts

The AACR’s 7th Biennial Special Conference on Ovarian Cancer will feature the latest advancements in ovarian cancer research, spanning disease pathogenesis, treatment strategies, and survivorship. In 2024, an estimated 19,680 new cases of ovarian cancer will be diagnosed in the U.S., with 12,740 projected deaths. While mortality rates have declined over the past four decades, ovarian cancer remains the most lethal gynecologic malignancy and the fifth leading cause of cancer-related death among women. The conference will explore key research areas, including tumor initiation, heterogeneity, immunology, clinical trial advancements, precision medicine approaches such as biomarker-driven therapies, targeted treatments, and antibody-drug conjugates (ADCs), as well as genomic innovations, particularly in DNA damage response (DDR) pathways. Emerging technologies in pathology, including artificial intelligence, multi-omics, and single-cell analysis, will also be explored for their potential to enhance diagnosis and therapeutic strategies. By promoting collaboration and knowledge exchange, the conference aims to advance ovarian cancer research and improve patient outcomes.